MRA Advisory Group Makes New Investment in Astera Labs, Inc. $ALAB

Key Points

• MRA Advisory Group acquired 3,594 Astera Labs shares during the second quarter, worth approximately $1.74 million. Institutional investors and hedge funds collectively own 60.47% of the company.
• Astera Labs exceeded quarterly expectations, reporting $0.80 in EPS versus the $0.69 consensus and $392.4 million in revenue, up 104.5% year over year. The company issued third-quarter 2026 EPS guidance of $1.16 to $1.21.
• Insiders sold 1.24 million shares worth approximately $358.9 million over the past 90 days, including significant sales by the CEO and a director. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $325.25, while the stock opened at $334.17.

MRA Advisory Group acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the second quarter, according to its most recent filing with the SEC. The firm acquired 3,594 shares of the company's stock, valued at approximately $1,736,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Royal Bank of Canada lifted its stake in shares of Astera Labs by 167.3% during the first quarter. Royal Bank of Canada now owns 152,453 shares of the company's stock valued at $9,097,000 after acquiring an additional 95,409 shares during the period. AQR Capital Management LLC increased its position in Astera Labs by 213.4% in the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company's stock worth $680,000 after purchasing an additional 7,756 shares during the period. Empowered Funds LLC increased its position in Astera Labs by 917.3% in the first quarter. Empowered Funds LLC now owns 4,639 shares of the company's stock worth $277,000 after purchasing an additional 4,183 shares during the period. First Trust Advisors LP raised its holdings in Astera Labs by 102.0% during the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company's stock worth $10,196,000 after purchasing an additional 56,952 shares during the last quarter. Finally, Brown Advisory Inc. raised its holdings in Astera Labs by 54.9% during the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company's stock worth $505,000 after purchasing an additional 1,977 shares during the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Astera Labs news, CEO Jitendra Mohan sold 111,214 shares of the company's stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $216.89, for a total value of $24,121,204.46. Following the completion of the sale, the chief executive officer owned 3,817,969 shares of the company's stock, valued at approximately $828,079,296.41. This represents a 2.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 136,974 shares of Astera Labs stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the transaction, the director directly owned 1,287,524 shares in the company, valued at approximately $569,098,483.24. This represents a 9.62% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 1,244,395 shares of company stock valued at $358,865,571. 10.40% of the stock is currently owned by company insiders.

Astera Labs Trading Up 0.8%

Shares of ALAB opened at $334.17 on Friday. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48. The stock has a market cap of $57.98 billion, a P/E ratio of 165.43, a price-to-earnings-growth ratio of 3.84 and a beta of 3.84. The stock's 50-day moving average price is $360.45 and its two-hundred day moving average price is $235.27.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company's revenue for the quarter was up 104.5% compared to the same quarter last year. During the same period in the previous year, the company earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities analysts forecast that Astera Labs, Inc. will post 1.86 EPS for the current year.

Analyst Upgrades and Downgrades

ALAB has been the topic of a number of research reports. Barclays upped their target price on shares of Astera Labs from $200.00 to $325.00 and gave the company an "equal weight" rating in a research report on Monday, July 20th. JPMorgan Chase & Co. boosted their price target on shares of Astera Labs from $205.00 to $280.00 and gave the stock an "overweight" rating in a research note on Wednesday, May 6th. Bank of America boosted their price target on shares of Astera Labs from $240.00 to $450.00 and gave the stock a "neutral" rating in a research note on Tuesday, June 23rd. Jefferies Financial Group increased their price objective on shares of Astera Labs from $270.00 to $450.00 and gave the company a "buy" rating in a report on Wednesday. Finally, Evercore reaffirmed an "outperform" rating and issued a $297.00 price objective on shares of Astera Labs in a research note on Tuesday, May 19th. Thirteen equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to data from MarketBeat, Astera Labs has a consensus rating of "Moderate Buy" and a consensus target price of $325.25.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source